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T he initia l clinical tria l of electroco nvu lsive th erapy (ECT) was performed
by Ugo Cerletti and Lucino Bin i at th e U niversity of Rome in 1938. T he
following paper will exam ine both the developments wh ich led to the first trial of
ECT, and th e use of ECT over th e subseque nt fifty years. Hopefull y, by
inv est igating the historical aspect s of the development and progression of ECT ,
a bette r understa nding of this treatment modali ty ca n be attained.
T he therapeutic use of electricity was not unique to ECT. T here is evidence
th at Ancient Romans used th e cu r rent generated by electric eels for the
treatment of headach es, gout, and to assist in obstetr ica l procedures. The recent
his tory o f th e th erapeutic use of electricity dates to 1744 when th e journal
entitle d " Electr icity and Medicine" was firs t publish ed. It was claimed here that
elec tric stimu li co u ld be curative for " neurologic and mental cases of paralysis
and ep ilepsy (1)." J.B. LeRoy in th e 175 5 ed ition of " Electr icity and Medicine"
detailed a case of hyste rical blindness whic h was cured with three applicat ions of
e lectric shock (1). In 1752 , Benjami n Franklin recorded th e use of an "elec tro
static mach ine to cu re a woman of hys terical fits (2). " By th e mid 19th century
the use of electrothera py had so progressed that G.B.C. Duchenne (often
refer red to as th e Fath er of Electrotherapy) would say, "No sin ce re neurologist
could p ract ice wit hout the use of electrotherapy (1)."
Bu t , despite th e documented use of electrotherapy through th e 19th cen-
tury, there is little ev idence that th is was of any influence in th e development of
ECT. The historical emphasis in the medicina l use of electricit y was on the
electric st im ulus in and of itsel f, whereas the e lectricity in ECT was used solely
for its co nv u lsan t proper t ies.
A more important co ntribution to the development of ECT was th e work of
Jul ius Wagner-Jauregg . It was a co mmon observation in th e lat e nineteenth
ce ntury tha t a wide variety of d isorders often improved clinically following
febrile ep isodes. Wagner-Jau regg, in 1917 , attempted to a lleviate the symptoms
of dementia paralyti ca (neuro-syphilis) by ind uc ing fever with th e intram uscular
injection of blood from patients with ma laria. Of th e fir st nine patient s he
investigated, three had a complete recovery, three had a temporary symptom-
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atic relief of symptoms, and three had no clinical change (3). Wi th th is, Wagner-
Jauregg essentially opened the door for the biological therapy of mental illness.
The 1930's were an exciting time in the treatment of schizophren ia. Three
therapies,-all extrapolations of Wagner-Jauregg's th eory- were developed
within a several year period. These included: insulin induced hypoglycemia ,
pharmacologically induced convulsive therapy, and leukotomy. T he first of
these was Manfred Sakel's insulin induced hypoglycemia. Although the hypogly-
cemia induced by Sakel occasionally resulted in convulsion, he did not beli eve
that the convulsion was therapeutically necessary. Rather , Sakel felt that the
hypoglycemia restricted the activity of that portion of the central nervous syste m
which was responsible for the psychopathology (4).
Sakel's technique was followed in 1934 by Ladislas Meduna's pharmaco logi-
cally induced convulsive therapy, which will be discussed later. Then, in 1936 ,
Egas Moniz developed the technique of leukotomy (lobotomy) for the treat ment
of psychosis. Moniz was later awarded a Nobel Prize in 1949 for his work on the
psychosurgerical treatment on schizophrenia.
Ladislas Meduna, who graduated from the University of Budapest Sch ool of
Medicine in 1921, attempted to treat schizophrenia by inducing seizures in his
patients. This theory was based on what Meduna felt to be a " b iologic antago-
nism between the epileptic state and schizophrenia (5). " Specifically, he ob-
served clinically that patients with schizophrenia frequently had a decrease in
their psychotic symptoms after spontaneous seizures. Moreover, based on au-
topsy findings, Meduna reported that epileptic brains were associated with a
"hyperplasia" of the glial system while schizophrenic brains were associated with
a "torpor" of this system (3). He therefore proposed that pharmacologically-
induced seizures may be of benefit for the treatment of schizophrenia.
However, Meduna commented in his unpublished auto-biography:
.. . at this time, however, I did not dare to think of cur ing schizophre-
nia, partly because ... to us, schizophrenia was an endogenous,
hereditary disease. Both expressions, endogenous and hereditary,
meant that the fate of the patient was determined at th e moment of
conception; the disease anchored in the ovum and spe r m; no thing
could change that fate (6).
Despite his reservations, Meduna eventually decided to test his th eory. On
January 23, 1934, he gave an intramuscular injection of camphor oil to a pa tient
who had been in a catatonic stupor for four years. Meduna described the
dramatic improvement in this patient with five camphor oi l induced seizures:
... on the morning of February 10, 1934, (two days aft er the fifth
injection) for the first time in four years, he got out of bed, began to
talk, requested breakfast, dressed himself without any help, was
interested in everything around him, and asked how long he had been
in the hospital. When we told him that he had spent four yea rs, he d id
not believe it (6).
70 JEFFERSON JO UR NAL OF PSYCHIATRY
After severa l trials with camphor oil , Meduna switched to pentylenetrazol
(Metrazol) as the epileptogenic stimulant because it produced an immediate
convulsion . Despite the initial criticism and opposition, pharmacologically-
induced seizures remained a preferred treatment modali ty for schizophrenia
until the advent ofECT.
In 1935, Meduna published " Versuche Uber Die Biologisch e Bee influssung
Des Ablaufes Der Schizophrenie" ("Attempts To Influence T he Cause of
Schizophrenia By Biological Means") which documented the results of his first
twenty-six schizophrenic patients to have pharmacologi call y ind uced seizures
(7). The results suggested that there did indeed seem to be an antagonistic
relationship between schizophrenia and convulsive episodes. Ten of the twenty-
six patients reportedly improved while sixteen were without clinical improve-
ment. Of note, the patients who did improve had received, on the average, 6.2
seizures; on the other hand, those who did not improve had an average of only
two seizures per patient. De spite these results, Meduna 's work was met with
much criticism. Meduna, in his autobiography, recalled th e reaction of Dr. Karl
Schaffer, the department chairman at the University of Budapest:
. .. he (Schaffer) called me a swindler, a humbug, a cheat ... how
dare I claim that I cured schizophrenia, an endogenous, heredi tary
disease. He knew what was in my mind-to publish , get newspaper
publicity, and make money! "If you dare publish this paper I disown
you. " ... this incident was the first shock I receiv ed for the disc overy
of shock therapy (6).
Ugo Cerletti, the chair of the Department of Neuropsych iat ry at the
University of Rome, utilized Meduna's pharmaco-convulsive therapy for the
treatment of hi s schizophrenic patients. Cerletti , wh ose laboratory research
involved an examination of the histopathologic changes in Am mon's horn of
dogs brains following electrically ind uced seizu res, postulated that electricity
could be substituted for Metrazol as the convulsive st imu lus for the treatment of
psychosis. However, Cerletti was reluctant to pursue this theory:
.. . the idea of submitting a man to convu lsant electric di sch arges was
considered as utopian, barbaric, and dangerous; in everyone's mind
was the specter of the electric chair (6).
Cerletti 's academic peers attempted to dissuade him from electrically induc-
ing conv u lsions in man. Among the arguments used against his proposal was the
idea that transcranial electricity was used to kill pigs in slaughter houses in
Rome. However, Cerletti determined, in research he perfor med at local slaugh-
ter houses, that the pigs were ac tually put into an elec trically-in duced epileptic
co ma during which time th eir necks were slashed. Ce rletti found that pigs could
ac tua lly tol erate a significant voltage across th e head wit hout subsequent death.
Lu cino Bini , who had no fo rmal tra ining in psyc hiatry, worked with Cerletti
on th e technical aspects of e lec tr ica l convu lsions . Bini noted that there was a
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high mortality in Cerletti's laboratory dogs following induced seizures. He
determined that this was secondary to the Viale method of e lectrode p lacement
in which the electrodes were placed in the dogs mouth and rectum. This
permitted electrical current to travel through the heart and occasionally cause
fatal arrhythmias. Bini subsequently initiated exper iments with bitemporal
electrode placement.
After significant deliberation and animal experimentation , Ce rlett i and Bini
were prepared to attempt ECT in man . In April , 1938 the first ECT was
performed by Cerletti and several members of his staff-Bini , Langhi , Acco-
nero, and Kalinowsky. Cerletti described the first patient, a 40 year old schizo-
phrenic:
... He expressed himself exclusively in an incomprehensible gib ber-
ish made up of odd neologisms and, since his arri val from Milan by
train without a ticket, not a thing had been ascertainable about his
identity (8).
Dr. Cerletti described the first ECT as follows:
... as was our custom with dogs, Bini and 1 fixed th e two electrodes
well wetted in salt solution, by an elastic band to th e patient 's te mples.
As a precaution, for our first test , we used reduced tension (70 volts)
with a duration of 0.2 seconds. Upon closing the circ uit, th ere was a
sudden jump of the patient on his bed with a very shor t tensing of a ll
his muscles; then he immediately collapsed on to th e bed without loss
of consciousness.
The patient presently started to sing at the top of his voice, then
fell silent. It was evident from our experience with dogs th at the
voltage had been held too low (8).
At this point, there was controversy among the observers whether a re peat
stimulus at a higher voltage should be attempted. In the midst of th is disc ussion,
the patient pleaded, in language that was no longer incomprehensibl e , "non una
seronda! mortifera!" ("not again it will kill me!"). Cerletti decided , against the
majority opinion , to repeat the electric stimulus:
1 (Cerletti) had the electrodes reapplied, and a 110 volt di sch arge was
sent through for 0.5 seconds. The immediate, very brief cra mping of
all the muscles was once again seen; after a slight pause , th e most
typical epileptic fit began to take place. True it is that all had their
hearts in the mouths and were truly oppressed during th e to nic phase
with apnea, ashy paleness, and cadaverous faci al cyanosis-an apnea
which, if it be awe inspiring in a spontaneous epileptic fit , now seemed
painfully never ending-until at the first deep, ster to rous inhalat ion,
and first chronic shutters, the blood ran more freel y in th e bystanders
veins as well: and, lastl y, to the immense relief of all co ncerned, was
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witnessed a characteristic, gradual awakening by step . The pati ent sat
up of his own accord, looked about him calmly with a vague smile, as
though asking what was expected of him. I asked him "what has been
happening to you?" He answered, with no more gibberish: " I don ' t
know, perhaps I have been asleep (8)."
The initial patient received thirteen more treatments of ECT over a two
month period and was discharged in complete remission. Unfortunately, the
patient was lost to follow-up after two years; but, he remained symptom free
until that time. The first public presentation of ECT was given by Cerletti at the
Medical Academy of Rome in May, 1938. ECT gradually gained acce pta nce for
the treatment of schizophrenia across Europe and by 1943 it had crossed the
Atlantic and was being used in America.
Although ECT, at its inception, was used primarily for th e treatm ent of
schizophrenia, investigators explored the efficacy of this treatment modal ity for
the entire gamut of psychiatric disorders. Within several years , ECT was a
relatively common treatment for the affective disorders, especially depression
with psychotic features and severe mania. Approximately 15 years afte r the first
trial of ECT,jarrie estimated, in a paper on the treatment of affecti ve di sorders,
that one third of the 60,000 hospitalized patients in England and Whales would
receive ECT (9).
The use of ECT was not without potential side-effects and complications.
Among these problems were a risk of fractures (especially of th e extre mities and
spinal compression fractures), a relatively high degree of psychic di str ess experi-
enced by the patients, and cognitive changes following treatments. Several
advances were made over the subsequent years to alleviate th ese probl ems.
Bennet, a psychiatrist, was instrumental in determining the muscle-relaxing
agent used by South American hunters to paralyze their prey. He was abl e to use
this agent, curare, during ECT and therefore significantly decreased th e ris k of
fractures (10). Succinyl-choline was later substituted for curare becau se of its
improved side-effect profile (II). In addition to muscle relax ants, barb itu rates
were administered both to decrease the patient's subjecti ve anxiety prior to
treatment and to decrease the anxiety associated with paralysis. With respect to
th e cognitive changes, it was determined that the un ilat eral , as opposed to
bitemporal, administration of the electrical current wou ld sti ll res u lt in a
generalized seizure and was less likely to produce cognitive changes. T hese
advances significantly decreased the complications and side-effec ts associated
with ECT.
The use of ECT in the 1940's was flourishing as there was no other effective
treatment for psychiatric disorders. However, with the introduction of neurolep -
tic medication, and subsequently antidepressants, ECT was used with decreasing
frequency. The administration of psychotropic medication was less time consum-
ing and certainly did not have the stigma associa ted with it th at ECT d id. In
AN HISTORICAL REVIEW OF ELECTROCONVULSIVE THERAPY 73
addition, much of the funding for research on the treatment of psychiatric
disorders was provided by pharmaceutical companies.
The psychotropic medications were not, however, the panacea that many
people had hoped. They did not have 100% cure rate and were also associated
with occasional side-effects and complications. Thus, despite th e decline in ECT
use following the introduction of psychotropic medication, th e 1980's saw a
gradual resurgence of ECT. In the United States in 1980, 2.5% of all hospi ta l-
ized psychiatric patients received ECT; and 13 % of all patients admitted to a
hospital with a primary diagnosis of an affective disorder received ECT (10).
While it is difficult, if not impossible, to perform a statistically sound study of the
efficacy ofECT, it has been suggested that ECT is at least as effective, if not more
effective, in the treatment of depression than psychopharmacologic interven-
tions.
Despite the resurgence of ECT, this continues to be an ext remely controver-
sial treatment for psychiatric disorders . The negative aspect of ECT is advanced
by movies like One.flew Over The Cuckoo's Nest and the anti-psychiatry movem e nt.
Sources like these often advance the view that ECT is a psychi atri c tool of
punishment and retribution.
In conclusion , the use ofelectricity for therapeutic purposes da tes to ancient
medicine. However, the concept of using electricity as a convu lsive agent fo r the
treatment of psychiatric disorders can be directly traced to th e pharmaco-
convulsive therapies of Meduna. Over the year s, significant improvements have
been made in the administration of this treatment in order to sign ificantly
decrease the associated adverse effects. At the present time, ECT appears to be
as effective as pharmacologic interventions for th e treatment of psych iat r ic
disorders. But, for many reasons, including the social stigma associated with its
use, ECT is most frequently used only as a last line of therapeutic in terventio n.
REFERENCES
1. Harm E: The origin and earl y history of electrotherapy and electroshock. Am J
Psychiatry III :933, 1955
2. Palmer RL: The history of shock treatment, in Electroco nvulsive Therapy: an
Appraisal. Edited by Palmer RL. Oxford Univer sity Press, Oxford, 1981 , p. 3
3. Fink M: Convulsive Therapy: Theory and Practice. Raven Press, New York, 1981
4. Sakel M: The methodologic use of hypoglycemia in the treatment of psychosis. AmJ
Psychiatry 94: 111-129, 1937
5. Meduna LV, Friedman E: The convulsive-irritative therapy of psychoses. J AMA
112:501-509,1939
6. Fink M: Meduna and the orig ins of convulsive therapy. Am J Psychiatry 141 :103 4-
1041 , 1984
7. Meduna LJ: Versuche uber die biologische beeinflussung des ablaufes der schizophre-
nia: Campher und cardiozolkramphe. Zeitschrift Fur Die Gesant e Neurologie Und
Psychiat rie. 152:235-262, 1935
8. Cerleui U: Old and new information about electros hock. Am J Psychiatry 107 :87,
1950
74 J EFFERSON JOURNA L OF PSYCHIATRY
9. Jarrie HF: Prognosis of depression treat ed by electric co nvulsive therapy. I: 132-
134 ,1954
10. Bennet AE : Preventing traumatic complications in co nvulsive shock therapy by
curare.JAMA 114 :322-324, 1940
11. Thompson WT, BlaineJD: Use ofECT in the U nited States in 1975 and 1980. AmJ
Psychiatry 144:5559, 1987
12. Holmberg G, Thesleff S: Succinyl-choline-iodide as a muscul ar relaxant in elec-
troshock therapy. AmJ Psychiatry 108:842-846, 1952
